Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 3Cognitive Dysfunction 2Tobacco Use Disorder 1Rectal Neoplasms 1Prostatic Neoplasms 1Neurotoxicity Syndromes 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Lung Neoplasms 1Ependymoma 1Craniopharyngioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Exercise 4Walking 2Memantine 2Donepezil 2beta Carotene 1Vitamin E 1Ultraviolet Therapy 1Time 1Tai Ji 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Sirolimus 1Riluzole 1Rehabilitation, Vocational 1Referral and Consultation 1Ramipril 1Radiotherapy, Intensity-Modulated 1Quality of Life 1Population Groups 1Pioglitazone 1Palliative Care 1Neuropsychological Tests 1Mindfulness-Based Stress Reduction 1Methods 1Interviews as Topic 1Ibuprofen 1Hormones 1Hematologic Tests 1Geritol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Cognitive Dysfunction × Memantine × Clear all
NCT02360215 2025-04-23

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

NRG Oncology

Phase 3 Completed
518 enrolled 40 charts
CNS

Brain Neoplasms, Cognitive Dysfunction

NCT04033419 2023-04-20

Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
55 enrolled 21 charts

Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡